• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】11804

【品名】allyl (3R,5S)-3,5-bis[[tert-butyl(diphenyl)silyl]oxy]-6-hydroxyhexanoate

【CA登记号】

【 分 子 式 】C41H52O5Si2

【 分 子 量 】681.03188

【元素组成】C 72.31% H 7.7% O 11.75% Si 8.25%

与该中间体有关的原料药合成路线共 2 条

合成路线1

该中间体在本合成路线中的序号:(XIX)

The condensation of 3-(4-fluorophenyl)-2-(hydroxymethyl)-1-isopropyl-1H-indole (IX) with trimethyl phosphite by means of oxalyl chloride in toluene gives 3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-ylmethylphosphonic acid dimethyl ester (X), which is condensed with erythro-3,5-di(tert-butyldiphenylsilyloxy)-6-oxohexanoic acid allyl ester (XI) by means of butyllithium in THF yielding erythro-3,5-di(tert-butyldiphenylsilyloxy)-7-[3-(4-fluorophenyl)-1H-indol-2-yl]-6(E)-heptenoic acid allyl ester (XII). The hydrolysis of (XII) by means of triphenylphosphine and palladium tetrakis triphenylphosphine in acetic acid affords the corresponding silylated free acid (XIII), which is finally deprotected with tetrabutylammonium fluoride in THF - acetic acid, and treated with NaOH. (racemic). The allyl ester (XI) is obtained as follows: The hydrogenation of fluoroglucinol (XIV) with H2 over W4 Raney Nickel in ethanol gives, after crystallization, cis-1,3,5-trihydroxycyclohexane (XV), which is treated with tert-butyldiphenylsilyl chloride and imidazole in DMF to afford the bis-silylated compound (XVI). The oxidation of (XVI) with pyridinium chlorochromate in dichloromethane gives the protected cyclohexanone (XVII), which is oxidized again with m-chloroperbenzoic acid in dichloromethane yielding cis-4,6-bis(tert-butyldiphenylsilyloxy hexahydrooxepin-2-one (XVIII). The hydrolysis of (XVIII) with trifluoroacetic acid and refluxing allyl alcohol affords erythro-3,5-bis(tert-butyldiphenylsilyloxy)-6-hydroxyhexanoic acid allyl ester (XIX), which is finally oxidized with pyridinium chlorochromate in dichloromethane to give the desired oxo-ester (XI).

1 Kathawala, F. (Novartis AG); Analogs of mevalolactone and derivs. thereof, processes for their production, pharmaceutical compsns. containing them and their use as pharmaceuticals. JP 1991047167; US 4739073; WO 8402131 .
2 Kapa, P.K. (Novartis AG); 6-Substituted-4-hydroxy-tetrahydropyran-2-ones. US 4571428 .
3 Chen, K.-M.; Hardtmann, G.E.; Lee, G.T.; Linder, J.; Wattanasin, S. (Novartis AG; Novartis Deutschland GmbH); Preparation of olefinic cpds. EP 0244364 .
4 Castaner, J.; Prous, J.; Fluvastatin Sodium. Drugs Fut 1991, 16, 9, 804.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(IX) 11794 [3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]methanol C18H18FNO 详情 详情
(X) 11795 dimethyl [3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]methylphosphonate C20H23FNO3P 详情 详情
(XI) 11796 allyl (3R,5S)-3,5-bis[[tert-butyl(diphenyl)silyl]oxy]-6-oxohexanoate C41H50O5Si2 详情 详情
(XII) 11797 allyl (3R,5S,6E)-3,5-bis[[tert-butyl(diphenyl)silyl]oxy]-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-6-heptenoate C59H66FNO4Si2 详情 详情
(XIII) 11798 (3R,5S,6E)-3,5-Bis[[tert-butyl(diphenyl)silyl]oxy]-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-6-heptenoic acid C56H62FNO4Si2 详情 详情
(XIV) 11799 1,3,5-Benzenetriol; Fluoroglucinol 108-73-6 C6H6O3 详情 详情
(XV) 11800 1,3,5-Cyclohexanetriol; cis,cis-1,3,5-Cyclohexanetriol dihydrate 50409-12-6 C6H12O3 详情 详情
(XVI) 11801 (3R,5S)-3,5-Bis[[tert-butyl(diphenyl)silyl]oxy]cyclohexanol C38H48O3Si2 详情 详情
(XVII) 11802 (3R,5S)-3,5-Bis[[tert-butyl(diphenyl)silyl]oxy]cyclohexanone C38H46O3Si2 详情 详情
(XVIII) 11803 (4R,6S)-4,6-Bis[[tert-butyl(diphenyl)silyl]oxy]-2-oxepanone C38H46O4Si2 详情 详情
(XIX) 11804 allyl (3R,5S)-3,5-bis[[tert-butyl(diphenyl)silyl]oxy]-6-hydroxyhexanoate C41H52O5Si2 详情 详情

合成路线2

该中间体在本合成路线中的序号:(XXIX)

3) The esterification of L-malic acid (XX) with methanol and acetyl chloride gives the dimethyl ester (XXI), which is reduced with borane-dimethyl sulfide in THF yielding 3(S),4-dihydroxybutyric acid methyl ester (XXII). Partial protection of (XXII) with trityl chloride in pyridine affords 3(S)-hydroxy-4-(trityloxy) butyric acid methyl ester (XXIII), which is hydrolyzed with NaOH to the corresponding free acid (XXIV). The condensation of (XXIV) with succinic acid monoallyl ester, magnesium salt (XXV) by means of the carbonyl diimidazole (DCI) in THF gives 5(S)-hydroxy-3-oxo-6-(trityloxy)hexanoic acid allyl ester (XXVI), which is reduced with triethylborane and NaBH4 in THF and treated with H2O2 at -70 C to afford 3(R),5(S)-6-(trityloxy)hexanoic acid allyl ester (XXVII). The protection of the hydroxyl groups of (XXVII) with tert-butyldiphenylsilyl chloride and imidazole in DMF gives the fully protected ester (XXVIII), which is treated with trifluoroacetic acid in dichloromethane yielding erythro-3(R),5(S)-bis(tert-butyldiphenylsilyloxy)-6-hydroxyhexanoic acid allyl ester (XXIX). The oxidation of (XXIX) with pyridinium chlorochromate in dichloromethane affords the oxo-ester (XXX), which is condensed with phosphonate (X), as in method 2 above, to give ester (XXXI). The hydrolysis of (XXXI) with triphenylphosphine and palladium tetrakis triphenylphosphine as before yields the protected acid (XXXII), which is finally deprotected with tetrabutylammonium fluoride, also as before. [3(R),5(S)-erythro-isomer].

1 Kathawala, F. (Novartis AG); Analogs of mevalolactone and derivs. thereof, processes for their production, pharmaceutical compsns. containing them and their use as pharmaceuticals. JP 1991047167; US 4739073; WO 8402131 .
2 Chen, K.-M.; Hardtmann, G.E.; Lee, G.T.; Linder, J.; Wattanasin, S. (Novartis AG; Novartis Deutschland GmbH); Preparation of olefinic cpds. EP 0244364 .
3 Kapa, P.K. (Novartis AG); 6-Substituted-4-hydroxy-tetrahydropyran-2-ones. US 4571428 .
4 Castaner, J.; Prous, J.; Fluvastatin Sodium. Drugs Fut 1991, 16, 9, 804.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(X) 11795 dimethyl [3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]methylphosphonate C20H23FNO3P 详情 详情
(XX) 11058 (S)-(+)-Hydroxysuccinic acid; (S)-(+)-Malic acid; (S)-(+)-2-Hydroxybutanedioic acid; L-(-)-Apple acid 97-67-6 C4H6O5 详情 详情
(XXI) 11806 dimethyl (2S)-2-hydroxybutanedioate 617-55-0 C6H10O5 详情 详情
(XXII) 11807 methyl (3S)-3,4-dihydroxybutanoate C5H10O4 详情 详情
(XXIII) 11808 methyl (3R)-3-hydroxy-5,5,5-triphenylpentanoate C24H24O3 详情 详情
(XXIV) 11809 (3R)-3-Hydroxy-5,5,5-triphenylpentanoic acid C23H22O3 详情 详情
(XXV) 11810 magnesium di[3-(allyloxy)-3-oxopropanoate] C12H14MgO8 详情 详情
(XXVI) 11811 allyl (5S)-5-hydroxy-3-oxo-6-(trityloxy)hexanoate C28H28O5 详情 详情
(XXVII) 11812 allyl (3R,5S)-3,5-dihydroxy-6-(trityloxy)hexanoate C28H30O5 详情 详情
(XXVIII) 11813 allyl (3R,5S)-3,5-bis[[tert-butyl(diphenyl)silyl]oxy]-6-(trityloxy)hexanoate C60H66O5Si2 详情 详情
(XXIX) 11804 allyl (3R,5S)-3,5-bis[[tert-butyl(diphenyl)silyl]oxy]-6-hydroxyhexanoate C41H52O5Si2 详情 详情
(XXX) 11815 allyl (3R,5R)-3,5-bis[[tert-butyl(diphenyl)silyl]oxy]-6-oxohexanoate C41H50O5Si2 详情 详情
(XXXI) 11797 allyl (3R,5S,6E)-3,5-bis[[tert-butyl(diphenyl)silyl]oxy]-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-6-heptenoate C59H66FNO4Si2 详情 详情
(XXXII) 11798 (3R,5S,6E)-3,5-Bis[[tert-butyl(diphenyl)silyl]oxy]-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-6-heptenoic acid C56H62FNO4Si2 详情 详情
Extended Information